Annals ofOncology

Volume: 5 - Number: 38 - March 15, 2005

Outstanding

It’s What’s Inside That Counts

Meeting Highlights: Updated International Expert Consensus on the Primary Therapy of Early Breast Cancer

Trends in Surgery and Chemotherapy for Women Diagnosed With Ovarian Cancer in the United States

Detection of Isolated Tumor Cells in Bone Marrow Is an Independent Prognostic Factor in Breast Cancer

AIDS Related Cancer

Incidence of Non–AIDS-Defining Cancers Before and During the Highly Active Antiretroviral Therapy Era in a Cohort of Human Immunodeficiency Virus–Infected Patients

Biology of neoplasia

Emerging Applications of the Tumor Necrosis Factor Family of Ligands and Receptors in Cancer Therapy

Breast Cancer

Phase I and II Study of Exisulind in Combination With Capecitabine in Patients With Metastatic Breast Cancer

Addition of Either Lonidamine or Granulocyte Colony-Stimulating Factor Does Not Improve Survival in Early Breast Cancer Patients Treated With High-Dose Epirubicin and Cyclophosphamide

Detection of Isolated Tumor Cells in Bone Marrow Is an Independent Prognostic Factor in Breast Cancer

Diagnosis in oncology

Unusual Locations of Involvement by Malignancies: CASE 1. TESTICULAR PLASMACYTOMA

Unusual Locations of Involvement by Malignancies: CASE 2. METASTATIC PHEOCHROMOCYTOMA TO THE COLON

Unusual Locations of Involvement by Malignancies: CASE 3. GASTRIC SIGNET RING CARCINOMA PRESENTING AS A DIFFUSE THIGH MASS

Unusual Locations of Involvement by Malignancies: CASE 4. BILATERAL HYPOPYON HERALDING CNS RELAPSE OF CUTANEOUS NATURAL KILLER CELL LYMPHOMA

Unusual Abdominal and Pelvic Tumors: CASE 1. AGGRESSIVE ANGIOMYXOMA OF THE PELVIS: RESPONSE TO LUTEINIZING HORMONE-RELEASING HORMONE AGONIST

Unusual Abdominal and Pelvic Tumors: CASE 2. SPONTANEOUS REGRESSION OF PERITONEAL IMPLANTS IN BORDERLINE OVARIAN TUMOR AFTER SALPINGO-OOPHORECTOMY

Unusual Abdominal and Pelvic Tumors: CASE 3. RESECTION OF ORIGINALLY INOPERABLE LIVER METASTASES OF GASTROINTESTINAL STROMAL TUMOR AFTER IMATINIB MESYLATE THERAPY

Unusual Abdominal and Pelvic Tumors: CASE 4. HYPERTROPHIC OSTEOARTHROPATHY ASSOCIATED WITH PULMONARY METASTASIS OF UTERINE LEIOMYOSARCOMA

Editorial

It’s What’s Inside That Counts

Down Syndrome and Acute Myeloid Leukemia: The Paradox of Increased Risk for Leukemia and Heightened Sensitivity to Chemotherapy

Hodgkin’s Lymphoma: The Hazards of Success

Gastrointestinal Cancer

Dynamic Expression Profile of p21WAF1/CIP1 and Ki-67 Predicts Survival in Rectal Carcinoma Treated With Preoperative Radiochemotherapy

Randomized Phase II Comparison of Dose-Intense Gemcitabine: Thirty-Minute Infusion and Fixed Dose Rate Infusion in Patients With Pancreatic Adenocarcinoma

Treatment of Locally Advanced Pancreatic Cancer in the Real World: Population-Based Practices and Effectiveness

Gynecologic Cancer

Trends in Surgery and Chemotherapy for Women Diagnosed With Ovarian Cancer in the United States

Small-Cell Carcinoma of the Cervix: Fourteen Years of Experience at a Single Institution Using a Combined-Modality Regimen of Involved-Field Irradiation and Platinum-Based Combination Chemotherapy

Head and Neck Carcinomas

Quantitative Tumor Apoptosis Imaging Using Technetium-99m–HYNIC Annexin V Single Photon Emission Computed Tomography

Hematologic Malignancies

Long-Term Cause-Specific Mortality of Patients Treated for Hodgkin’s Disease

Secondary Myeloid Leukemia and Myelodysplastic Syndromes in Patients Treated for Hodgkin’s Disease: A Report From the German Hodgkin’s Lymphoma Study Group

Melanoma

Vaccination With Irradiated, Autologous Melanoma Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor by Adenoviral-Mediated Gene Transfer Augments Antitumor Immunity in Patients With Metastatic Melanoma

Phase II Study of Temozolomide Plus Thalidomide for the Treatment of Metastatic Melanoma

Pediatric Oncology

Increased Age at Diagnosis Has a Significantly Negative Effect on Outcome in Children With Down Syndrome and Acute Myeloid Leukemia: A Report From the Children’s Cancer Group Study 2891

Long-Term Event-Free Survival After Intensive Chemotherapy for Ewing’s Family of Tumors in Children and Young Adults

Special Articles

Meeting Highlights: Updated International Expert Consensus on the Primary Therapy of Early Breast Cancer

Supportive Care and Quality of Life

Beyond the Development of Health-Related Quality-of-Life (HRQOL) Measures: A Checklist for Evaluating HRQOL Outcomes in Cancer Clinical Trials—Does HRQOL Evaluation in Prostate Cancer Research Inform Clinical Decision Making?

Health Status and Quality of Life in Patients With Early-Stage Hodgkin’s Disease Treated on Southwest Oncology Group Study 9133

Catheter Design Influences Recurrence of Catheter-Related Bloodstream Infection in Children With Cancer

Unknown Primary Site Cancer

Cisplatin in Combination With Either Gemcitabine or Irinotecan in Carcinomas of Unknown Primary Site: Results of a Randomized Phase II Study—Trial for the French Study Group on Carcinomas of Unknown Primary (GEFCAPI 01)